Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$3.3 - $8.89 $2.59 Million - $6.99 Million
-786,200 Reduced 79.82%
198,800 $1.62 Million
Q3 2023

Nov 14, 2023

BUY
$4.44 - $8.79 $4.37 Million - $8.66 Million
985,000 New
985,000 $4.48 Million
Q2 2022

Aug 15, 2022

SELL
$6.38 - $18.33 $1.42 Million - $4.07 Million
-222,000 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$12.38 - $19.1 $2.75 Million - $4.24 Million
222,000 New
222,000 $3.7 Million
Q3 2020

Nov 13, 2020

SELL
$27.75 - $36.3 $577,200 - $755,039
-20,800 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$27.21 - $41.0 $565,968 - $852,800
20,800 New
20,800 $571,000
Q4 2018

Feb 12, 2019

SELL
$7.51 - $11.93 $97,307 - $154,577
-12,957 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$11.25 - $17.7 $145,766 - $229,338
12,957 New
12,957 $146,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.74B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.